Kezar Life Sciences Inc (KZR) stock news · $53.9M cap
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
This KZR news page leads with what Kezar Life Sciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for KZR yet. We will not pad this page with generic market recap.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the KZR stock page; for the tape open the quote page.
Not investment advice.